Return to homepagePandemic Pact

Emergency C-19 Response

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:6 publications

Grant number: MC_PC_21004

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2021

  • Known Financial Commitments (USD)

    $30,719.74

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Professor Pontiano Kaleebu

  • Research Location

    Uganda

  • Lead Research Institution

    MRC/UVRI and LSHTM Uganda Research Unit

  • Research Priority Alignment

    N/A

  • Research Category

    14

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The MRC is pleased to confirm additional capital funding for the MRC/UVRI and LSHTM Research Unit Uganda up to the value of £27,000 to support the Centres important work on COVID-19. This exceptional award is being made in recognition of the fact that research will be critical in overcoming this epidemic.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Rapid Replacement of SARS-CoV-2 Variants by Delta and Subsequent Arrival of Omicron, Uganda, 2021.

SARS-CoV-2 Variants, South Sudan, January-March 2021.

Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.

Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.

Alternate primers for whole-genome SARS-CoV-2 sequencing.

Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples.